Hjem › Urotelial (overgangscelle) karcinom › Ohio › Columbus
Kliniske studier for Urotelial (overgangscelle) karcinom i Columbus, OH
9 studier for Urotelial (overgangscelle) karcinom søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
RekruttererFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- og 11 flere
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruttererObservasjonsstudie
- Ohio State University, Columbus
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
RekruttererFase 3
- The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruttererFase 2
- Ohio State University Hospital, Columbus
- Ohio State University, Columbus
- OSU Wexner Medical Center & James Cancer Hospital, Columbus
- og 2 flere
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekruttererFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
RekruttererFase 2
- Site 02-017 - Central Ohio Urology Group, Gahanna · 7 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Columbus
Urotelial (overgangscelle) karcinom-studier i andre byer
- Nashville, TN23 studier
- New York City, NY22 studier
- Houston, TX19 studier
- Dallas, TX18 studier
- Edison, NJ18 studier
- Los Angeles, CA17 studier
- Queens, NY15 studier
- Chicago, IL14 studier
- Arlington, VA12 studier
- Boston, MA11 studier
- San Antonio, TX11 studier
- Austin, TX10 studier
Andre studier i Columbus
- Ikke-småcellet lungekreft57 studier
- Brystkreft40 studier
- Eggstokkreft39 studier
- Kreft (alle typer)38 studier
- Lungekreft37 studier
- Akut myelogen leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastatisk kreft27 studier
- Endometriekreft25 studier
- Prostatakreft24 studier
- Multipelt myelom24 studier
- Kolorektal kreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.